At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MC1267, A Randomized, Blinded Pilot Placebo-Controlled Trial With Oral Serum Bovine Immunoglobulin (SBI) to Assess Quality of Life and the Faster Post-Operative Recovery of Gynecological Cancer Patients
In Brief
A Phase 2 clinical trial evaluating serum-derived bovine immunoglobulin protein isolate, placebo, and 3 other interventions for Female Reproductive Cancer. Completed, enrolled 58 participants across 1 site.
Detailed Summary
This randomized pilot phase II trial studies how well serum bovine immunoglobulin protein isolate works in improving quality of life and post-operative recovery in patients with cancer of the female reproductive tract after undergoing surgery. Serum bovine immunoglobulin may help provide nutrition to patients who are not able to eat or digest ordinary food. This may improve the quality of life of patients with gynecological cancer and help them recover more quickly from surgery.
Study Details
Timeline
Interventions
Given PO
Given PO
Correlative studies
Ancillary studies
Ancillary studies